Literature DB >> 22879689

The Relationship between Substance Abuse Performance Measures and Mutual Help Group Participation after Treatment.

Gail K Strickler1, Sharon Reif, Constance M Horgan, Andrea Acevedo.   

Abstract

We examined the relationship between treatment quality, using during-treatment process measures, and mutual help group (e.g., Alcoholics Anonymous) attendance after outpatient substance use disorder (SUD) treatment for 739 clients in the Alcohol and Drug Services Study. Logistic regression models estimated any and regular mutual help attendance after treatment. Clients referred to mutual help groups were significantly more likely to attend any mutual help after treatment. Results were mixed for facility offered mutual help groups; treatment engagement and retention were not significant. These findings offer treatment providers further evidence of the importance of referring clients to post-treatment mutual help groups, an effective, low-cost option.

Entities:  

Year:  2012        PMID: 22879689      PMCID: PMC3412672          DOI: 10.1080/07347324.2012.663305

Source DB:  PubMed          Journal:  Alcohol Treat Q        ISSN: 0734-7324


  31 in total

1.  Utilization of AA by Hispanic and non-Hispanic white clients receiving outpatient alcohol treatment.

Authors:  J Scott Tonigan; William R Miller; Patricia Juarez; Miguel Villanueva
Journal:  J Stud Alcohol       Date:  2002-03

2.  An exploration of the effect of on-site 12-step meetings on post-treatment outcomes among polysubstance-dependent outpatient clients.

Authors:  Alexandre Laudet; Virginia Stanick; Brian Sands
Journal:  Eval Rev       Date:  2007-12

3.  Are Washington Circle performance measures associated with decreased criminal activity following treatment?

Authors:  Deborah W Garnick; Constance M Horgan; Margaret T Lee; Lee Panas; Grant A Ritter; Steve Davis; Tracy Leeper; Rebecca Moore; Mark Reynolds
Journal:  J Subst Abuse Treat       Date:  2007-05-23

Review 4.  Facilitating involvement in twelve-step programs.

Authors:  Dennis M Donovan; Anthony S Floyd
Journal:  Recent Dev Alcohol       Date:  2008

5.  Should patients' religiosity influence clinicians' referral to 12-step self-help groups? Evidence from a study of 3,018 male substance abuse patients.

Authors:  A Winzelberg; K Humphreys
Journal:  J Consult Clin Psychol       Date:  1999-10

6.  A longitudinal model of intake symptomatology, AA participation and outcome: retrospective study of the project MATCH outpatient and aftercare samples.

Authors:  G J Connors; J S Tonigan; W R Miller
Journal:  J Stud Alcohol       Date:  2001-11

7.  Drug treatment completion and post-discharge employment in the TOPPS-II Interstate Cooperative Study.

Authors:  Amelia M Arria
Journal:  J Subst Abuse Treat       Date:  2003-07

8.  The relationship of post-acute home care use to Medicaid utilization and expenditures.

Authors:  Susan M C Payne; David L DiGiuseppe; Negussie Tilahun
Journal:  Health Serv Res       Date:  2002-06       Impact factor: 3.402

9.  Using propensity scores to adjust for selection bias when assessing the effectiveness of Alcoholics Anonymous in observational studies.

Authors:  Yu Ye; Lee Ann Kaskutas
Journal:  Drug Alcohol Depend       Date:  2009-05-20       Impact factor: 4.492

Review 10.  Concerns about dose and underutilization of twelve-step programs: models, scales, and theory that inform treatment planning.

Authors:  Richard N Cloud; J B Kingree
Journal:  Recent Dev Alcohol       Date:  2008
View more
  2 in total

1.  Intensive referral to mutual-help groups: A field trial of adaptations for rural veterans.

Authors:  Kathleen M Grant; Lance Brendan Young; Kimberly A Tyler; Jamie L Simpson; R Dario Pulido; Christine Timko
Journal:  Patient Educ Couns       Date:  2017-07-14

2.  Intensive Referral of Veterans to Mutual-Help Groups: A Mixed-Methods Implementation Evaluation.

Authors:  Lance Brendan Young; Kathleen M Grant; R Dario Pulido; Jamie L Simpson; Kimberly A Tyler; Christine Timko
Journal:  Alcohol Treat Q       Date:  2017-12-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.